Last reviewed · How we verify

NCT04309786

Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic Esophagitis

Completed Last updated 21 October 2022
What this trial tests

trial in Eosinophilic Esophagitis in 98 participants. Completed in 26 April 2021.

Timeline
11 April 2019
Primary endpoint
26 April 2021
26 April 2021

Quick facts

Lead sponsorUniversity of California, San Diego
StatusCompleted
Study typeOBSERVATIONAL
Enrollment98
Start date11 April 2019
Primary completion26 April 2021
Estimated completion26 April 2021
Sites1 location across United States

Conditions studied

Sponsor

University of California, San Diego

Who can join

Adults 8 to 18, any sex, with Eosinophilic Esophagitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Eosinophilic esophagitis

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Sleep, Anxiety, Somatization, Quality of Life, and Resilience in Pediatric Patients With Eosinophilic Esophagitis.
    Jensen ET, Chaiboonma K, Ayala O, Proia A, et al · · 2024 · cited 3× · PMID 38205930 · DOI 10.14309/ctg.0000000000000672

Verify or expand the search:

Other recruiting trials for Eosinophilic Esophagitis

Currently open trials in the same condition.

Other University of California, San Diego trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04309786.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing